Experiment 289616

Worktypes

PHARMACOLOGY OF COMPOUND - IN VITRO

Compounds isolated

LABDA-8-14-DIEN-13(R)-OL,7-ALPHA-HYDROPEROXY: 4-O-ACETYL-ALPHA-L-6-DEOXY-IDOPYRANOSIDELABDA-7-14-DIEN-13(R)-OL-4-O-ACETYL-ALPHA-L-6-DEOXYPYRANOSIDELABDAN-18-OL,8-13-EPOXY:LABDA-7-14-DIEN-13(R)-OL-4-O-ACETYL-ALPHA-L-RHAMNOPYRANOSIDELABDA-7-14-DIEN-13(R)-OL-2-O-ACETYL-ALPHA-L-RHAMNOPYRANOSIDELABDA-7-14-DIEN-13(R)-OL-ALPHA-L-RHAMNOPYRANOSIDELABDA-7-14-DIEN-13(R)-OL-3-O-ACETYL-ALPHA-L-RHAMNOPYRANOSIDELABD-14-EN-8-13-DIOLMANOYL OXIDE-18-OIC ACID,13-EPI: ENT:MANOYL OXIDE-18-OIC ACID,ENT:LABDA-7-14-DIEN-13(R)-OL-ALPHA-L-6-DEOXY-IDOPYRANOSIDE

Details

PropertyValue
Pharmacology
CYTOTOXIC ACTIVITY
OrganismAster oharai (ASTERACEAE)
CitationCHOI,SZ: KWON,HC: CHOI,SU: LEE,KR:. (2002). FIVE NEW LABDANE DITERPENES FROM ASTER OHARAI.. 65(8)
Amount utilized
Compound isolated
DiseaseVS.SNB-19 CELLS.
Dose amount>10.0 MCG
Number13
Qualitative resultINACTIVE
AnimalCELL CULTURE
Per unitML
Dose expressionIC50